Open Access
Med Sci (Paris)
Volume 34, Number 12, Décembre 2018
Page(s) 1019 - 1021
Section Editorial
Published online 09 January 2019
  1. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 ; 131 : 861–72. [CrossRef] [PubMed] [Google Scholar]
  2. Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014 ; 346 : 1258096. [Google Scholar]
  3. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000 ; 288 : 669–72. [Google Scholar]
  4. Hacein-Bey Abina S, Gaspar HB, Blondeau J, et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. Jama 2015 ; 313 : 1550–63. [CrossRef] [PubMed] [Google Scholar]
  5. Jordan B. Les débuts de CRISPR en thérapie génique. Med Sci (Paris) 2016 ; 32 : 1035–7. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Pushpakom S, Iorio F, Eyers PA, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 2018 Oct 12. doi: 10.1038/nrd.2018.168. [Google Scholar]
  7. Gordon LB, Shappell H, Massaro J, et al. Association of Lonafarnib treatment vs no treatment with mortality rate in patients with Hutchinson-Gilford progeria syndrome. JAMA 2018 ; 319 : 1687–95. [CrossRef] [PubMed] [Google Scholar]
  8. De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003 ; 300 : 2055. [Google Scholar]
  9. Venot Q, Blanc T, Rabia SH, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 2018 ; 558 : 540–6. [CrossRef] [PubMed] [Google Scholar]
  10. Bassez G, Audureau E, Hogrel JY, et al. Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial. Brain 2018 ; 141 : 2855–65. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.